Invasive fungal sinusitis: an effective combined treatment in five haematological patients

Claudia Vener1, Maria Carrabba, Nicola S Fracchiolla

  • 1U.O. Ematologia I, Centro Trapianti di Midollo, Università degli Studi di Milano & Fondazione Istituto di Ricovero e Cura a Carattere Scientifico Ospedale Policlinico, Mnagiagalli e Regina Elena, Milano, Italy.

Leukemia & Lymphoma
|August 19, 2007
PubMed

Insights

Invasive fungal rhinosinusitis (IFR) in immunocompromised patients requires prompt treatment. A combined surgical and antifungal approach, including local sinus instillation, improved survival rates in a small patient cohort.

Area of Science:

  • Infectious Diseases
  • Otolaryngology
  • Hematology

Background:

  • Invasive fungal rhinosinusitis (IFR) is a severe infection with subtle onset, often leading to delayed diagnosis and poor outcomes.
  • Hematological patients are particularly vulnerable to IFR, with high mortality rates if not treated promptly.

Purpose of the Study:

  • To describe a comprehensive pre- and post-operative management strategy for hematological patients diagnosed with IFR.
  • To evaluate the efficacy of a novel treatment approach combining systemic antifungals, surgical debridement, and local sinus instillation.

Main Methods:

  • A retrospective review of five hematological patients with IFR.
  • Treatment involved systemic antifungal therapy, endoscopic surgical debridement, and post-operative local amphotericin-B instillation via a new ethmoidal drainage system.

Main Results:

  • All five patients achieved remission of IFR.
  • After a median follow-up of 32 months, three patients survived, with two deaths attributed to other causes.
  • Two patients with initial brain progression of IFR survived.

Conclusions:

  • A multidisciplinary approach incorporating surgery, systemic antifungals, and innovative local post-operative sinus therapy can effectively manage IFR in hematological patients.
  • This comprehensive strategy may improve survival rates and facilitate radical antifungal sinus treatment.

Related Concept Videos

Cryptococcal Meningitis01:27

Cryptococcal Meningitis

Cryptococcal meningitis is a life-threatening opportunistic infection predominantly associated with HIV/AIDS, accounting for over 100,000 deaths annually worldwide. However, it also affects individuals with other forms of immunosuppression, including those undergoing immunosuppressive therapy, organ transplant recipients, patients with innate immunodeficiencies, and individuals with hematological disorders. The infection is caused mainly by Cryptococcus neoformans and Cryptococcus gattii,...
Antifungal Agents01:15

Antifungal Agents

Amphotericin B is a broad-spectrum antifungal agent that exploits structural differences between fungal and mammalian cell membranes. Its amphipathic structure—featuring a hydrophobic polyene-lactone ring and a hydrophilic region containing mycosamine and carboxylic acid groups—enables selective binding to ergosterol, a sterol predominantly found in fungal plasma membranes. This selective interaction underlies the drug’s antifungal activity, although weak binding to cholesterol contributes to...
Bone Marrow Sampling and Transplants01:22

Bone Marrow Sampling and Transplants

Bone marrow transplant is a potential cure for several diseases, including cancer and specific genetic disorders. Notably, this procedure is applicable for patients suffering from aplastic anemia, certain types of leukemia, severe combined immunodeficiency disease (SCID), Hodgkin's disease, non-Hodgkin's lymphoma, multiple myeloma, thalassemia, sickle-cell disease, and certain cancers.
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy the...
Treatment Resistent Cancers02:56

Treatment Resistent Cancers

Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...